INO insider transactions
Inovio Pharmaceuticals Inc. (INO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for INO
- SEC Form 4 filed by Director Yarno Wendy L4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Director Shepard Jay4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Director Miller Ann Calby4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Director Weiner David B.4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Director Zoth Lota S.4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Director Dansey Roger D4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Director Benito Simon X4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Scientific Officer Humeau Laurent converted options into 6,027 shares and covered exercise/tax liability with 2,163 shares, increasing direct ownership by 9% to 46,823 units (SEC Form 4) (for withholding tax)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Medical Officer Sumner Michael John converted options into 9,450 shares and covered exercise/tax liability with 2,693 shares, increasing direct ownership by 19% to 42,038 units (SEC Form 4) (for tax liability)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Executive Officer Shea Jacqueline Elizabeth converted options into 28,296 shares and covered exercise/tax liability with 12,306 shares, increasing direct ownership by 17% to 111,021 units (SEC Form 4) to satisfy withholding obligation4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- CFO Kies Peter converted options into 8,700 shares and covered exercise/tax liability with 4,688 shares, increasing direct ownership by 10% to 42,854 units (SEC Form 4) (for tax liability)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Executive Officer Shea Jacqueline Elizabeth converted options into 17,744 shares and covered exercise/tax liability with 7,717 shares, increasing direct ownership by 12% to 95,031 units (SEC Form 4) to cover taxes4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- CFO Kies Peter converted options into 4,771 shares and covered exercise/tax liability with 2,571 shares, increasing direct ownership by 6% to 38,842 units (SEC Form 4) (for tax liability)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Scientific Officer Humeau Laurent converted options into 4,771 shares and covered exercise/tax liability with 1,712 shares, increasing direct ownership by 8% to 42,959 units (SEC Form 4) to cover withholding tax4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Medical Officer Sumner Michael John converted options into 2,385 shares and covered exercise/tax liability with 680 shares, increasing direct ownership by 5% to 35,281 units (SEC Form 4) (for tax liability)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Sumner Michael John4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Humeau Laurent4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Shea Jacqueline Elizabeth4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Sumner Michael John4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by CFO Kies Peter4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Scientific Officer Humeau Laurent converted options into 12,376 shares and covered exercise/tax liability with 5,098 shares, increasing direct ownership by 22% to 39,900 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- CFO Kies Peter converted options into 15,644 shares and covered exercise/tax liability with 9,259 shares, increasing direct ownership by 21% to 36,642 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Executive Officer Shea Jacqueline Elizabeth covered exercise/tax liability with 21,714 shares and converted options into 47,033 shares, increasing direct ownership by 42% to 85,004 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Medical Officer Sumner Michael John covered exercise/tax liability with 3,903 shares and converted options into 16,560 shares, increasing direct ownership by 71% to 30,507 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Director Weiner David B. converted options into 972 shares, increasing direct ownership by 1% to 87,592 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Medical Officer Sumner Michael John converted options into 2,916 shares, increasing direct ownership by 20% to 17,850 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Shea Jacqueline Elizabeth4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Humeau Laurent4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Director Zoth Lota S. converted options into 2,167 shares, increasing direct ownership by 33% to 8,726 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Director Miller Ann Calby converted options into 2,167 shares, increasing direct ownership by 28% to 9,877 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Director Shepard Jay converted options into 2,167 shares, increasing direct ownership by 31% to 9,209 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Director Benito Simon X converted options into 2,167 shares, increasing direct ownership by 22% to 12,191 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Director Yarno Wendy L converted options into 2,167 shares, increasing direct ownership by 26% to 10,512 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by CFO Kies Peter4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Director Dansey Roger D converted options into 2,167 shares, increasing direct ownership by 32% to 8,916 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Sumner Michael John4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Director Weiner David B. converted options into 2,167 shares, increasing direct ownership by 3% to 86,620 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Medical Officer Sumner Michael John converted options into 2,385 shares and covered exercise/tax liability with 680 shares, increasing direct ownership by 13% to 14,934 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Executive Officer Shea Jacqueline Elizabeth converted options into 17,744 shares and covered exercise/tax liability with 7,717 shares, increasing direct ownership by 20% to 59,685 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- CFO Kies Peter converted options into 4,771 shares and covered exercise/tax liability with 2,566 shares, increasing direct ownership by 8% to 30,257 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Scientific Officer Humeau Laurent converted options into 4,771 shares and covered exercise/tax liability with 1,708 shares, increasing direct ownership by 10% to 32,622 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Executive Officer Shea Jacqueline Elizabeth converted options into 5,500 shares and covered exercise/tax liability with 2,392 shares, increasing direct ownership by 7% to 49,658 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Scientific Officer Humeau Laurent converted options into 8,865 shares and covered exercise/tax liability with 3,643 shares, increasing direct ownership by 21% to 29,559 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Medical Officer Sumner Michael John converted options into 5,010 shares, increasing direct ownership by 61% to 13,229 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Executive Officer Shea Jacqueline Elizabeth converted options into 24,484 shares and covered exercise/tax liability with 11,581 shares, increasing direct ownership by 38% to 46,550 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- CFO Kies Peter converted options into 9,007 shares and covered exercise/tax liability with 5,322 shares, increasing direct ownership by 15% to 28,052 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Director Weiner David B. converted options into 1,944 shares, increasing direct ownership by 2% to 84,453 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Sumner Michael John4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Chief Medical Officer Sumner Michael John converted options into 2,917 shares, increasing direct ownership by 55% to 8,219 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Zoth Lota S.4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Shepard Jay4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Miller Ann Calby4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Weiner David B.4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Yarno Wendy L4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Benito Simon X4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- SEC Form 4 filed by Dansey Roger D4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Miller Ann Calby converted options into 2,166 shares, increasing direct ownership by 39% to 7,710 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Benito Simon X converted options into 2,166 shares, increasing direct ownership by 28% to 10,024 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Shepard Jay converted options into 2,166 shares, increasing direct ownership by 44% to 7,042 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)
- Kies Peter converted options into 4,771 shares and covered exercise/tax liability with 2,562 shares, increasing direct ownership by 10% to 24,367 units (SEC Form 4)4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Issuer)